Diferencia entre revisiones de «Template:Neurocysticercosis antibiotics»
(Created page with "===Albendazole=== *15mg/kg/day divided in 2 doses<ref>Garcia HH, Pretell EJ, Gilman RH, et al. A trial of antiparasitic treatment to reduce the rate of seizures due to cer...") |
(Convert to AntibioticDose template for SMW integration) |
||
| Línea 1: | Línea 1: | ||
===[[Albendazole]]=== | ===[[Albendazole]]=== | ||
*15mg/kg/day divided in 2 doses<ref>Garcia HH, Pretell EJ, Gilman RH, et al. A trial of antiparasitic treatment to reduce the rate of seizures due to cerebral cysticercosis. N Engl J Med. 2004;350(3):249-58.</ref> | *{{AntibioticDose|disease=Neurocysticercosis|drug=Albendazole|dose=15mg/kg/day divided in 2 doses|context=First line therapy}}<ref>Garcia HH, Pretell EJ, Gilman RH, et al. A trial of antiparasitic treatment to reduce the rate of seizures due to cerebral cysticercosis. N Engl J Med. 2004;350(3):249-58.</ref> | ||
===[[Praziquantel]]=== | ===[[Praziquantel]]=== | ||
*Second line therapy | *Second line therapy | ||
*50-100mg/kg/day divided in 3 doses <ref>Sotelo J. et al. Albendazole vs praziquantel for therapy for neurocysticercosis. A controlled trial. Arch Neurol. May 1988;45(5):532-4</ref> | *{{AntibioticDose|disease=Neurocysticercosis|drug=Praziquantel|dose=50-100mg/kg/day divided in 3 doses|context=Second line therapy}}<ref>Sotelo J. et al. Albendazole vs praziquantel for therapy for neurocysticercosis. A controlled trial. Arch Neurol. May 1988;45(5):532-4</ref> | ||
Revisión actual - 02:27 20 mar 2026
Albendazole
- Albendazole 15mg/kg/day divided in 2 doses[1]
Praziquantel
- Second line therapy
- Praziquantel 50-100mg/kg/day divided in 3 doses[2]
- ↑ Garcia HH, Pretell EJ, Gilman RH, et al. A trial of antiparasitic treatment to reduce the rate of seizures due to cerebral cysticercosis. N Engl J Med. 2004;350(3):249-58.
- ↑ Sotelo J. et al. Albendazole vs praziquantel for therapy for neurocysticercosis. A controlled trial. Arch Neurol. May 1988;45(5):532-4